Journal Mobile Options
Table of Contents
Vol. 89, No. 3-4, 2000
Issue release date: 2000
Cytogenet Cell Genet 89:177–184 (2000)

A new aspartyl protease on 21q22.3, BACE2, is highly similar to Alzheimer’s amyloid precursor protein β-secretase

Solans A. · Estivill X. · de la Luna S.
Down Syndrome Research Group, Medical and Molecular Genetics Center, IRO, Hospital Duran i Reynals, Barcelona (Spain)

Individual Users: Register with Karger Login Information

Please create your User ID & Password

Contact Information

I have read the Karger Terms and Conditions and agree.

To view the fulltext, please log in

To view the pdf, please log in



Down syndrome individuals develop abnormalities of most organs, including all the pathological and neurochemical features of Alzheimer’s disease, by the early age of 30 yr. Here, we report the isolation and characterization of BACE2, a gene mapping on human chromosome 21q22.3, which is highly similar to a transmembrane aspartyl protease, BACE (for beta-site APP-cleaving enzyme), which is able to catalyze the β-secretase cleavage of Alzheimer’s amyloid precursor protein (APP). BACE2 is expressed in a wide variety of organs and tissues, with several transcripts due to alternative splicing and the use of two polyadenylation signals. The BACE2 gene product is a 518 amino acid protein with the signature of an aspartic protease, a 20-residue signal peptide, and two putative N-glycosylation sites. In addition, and similarly to BACE, BACE2 differs from the other members of the human aspartic protease family in the number and distribution of putative disulfide bonds and in the presence of an extended C-terminal region which contains a predicted transmembrane segment. BACE2 could be involved in the Alzheimer-like neuropathology of Down syndrome, as well as in Alzheimer’s disease linked to chromosome 21 but not showing mutations in APP.   

Copyright © 2000 S. Karger AG, Basel

Copyright / Drug Dosage

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher or, in the case of photocopying, direct payment of a specified fee to the Copyright Clearance Center.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in goverment regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.


  1. Altschul SF, Madden TL, Schaffer AA, Zhang J, Zhang Z. Miller W, Lipman DJ: Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. Nucl Acids Res 25:3389–3402 (1997).
  2. Azuma T, Liu WG, Vander Laan DJ, Bowcock AM, Taggart RT: Human gastric cathepsin E gene: multiple transcripts result from alternative polyadenylation of the primary transcripts of a single gene locus at 1q31→q32. J biol Chem 267:1609–1614 (1992).

    External Resources

  3. Buxbaum JD, Liu KN, Luo Y, Slack JL, Stocking KL, Peschon JJ, Johnson RS, Castner BJ, Cerretti DP, Black RA: Evidence that tumor necrosis factor alpha converting enzyme is involved in regulated alpha-secretase cleavage of the Alzheimer amyloid protein precursor. J biol Chem 273:27765–27767 (1998).
  4. De Strooper B, Saftig P, Craessaerts K, Vanderstichele H, Guhde G, Annaert W, von Figura K, van Leuven F: Deficiency of presenilin-1 inhibits the normal cleavage of amyloid precursor protein. Nature 391:387–390 (1998).
  5. Epstein CJ: Down syndrome (trisomy 21), in Scriver CR, Beaudet AL, Sly WS, Valle D (eds): The Metabolic and Molecular Basis of Inherited Disease, Vol 1, pp 749–794 (McGraw-Hill, New York 1995).
  6. Guimera J, Pucharcos C, Domenech A, Casas C, Solans A, Gallardo T, Ashley J, Lovett M, Estivill X, Pritchard M: Cosmid contig and transcriptional map of three regions of human chromosome 21q22: identification of 37 novel transcripts by direct selection. Genomics 45:59–67 (1997).
  7. Haass C, Schlossmacher MG, Hung AY, Vigo-Pelfrey C, Mellon A, Ostaszewski BL, Lieberburg I, Koo EH, Schenk D, Teplow DB, Selkoe DJ: Amyloid beta-peptide is produced by cultured cells during normal metabolism. Nature 359:322–325 (1992).
  8. Hayano T, Sogawa K, Ichihara Y, Fujii-Kuriyama Y, Takahashi K: Primary structure of human pepsinogen C gene. J biol Chem 263:1382–1385 (1988).
  9. Hobart PM, Fogliano M, O’Connor BA, Schaefer IM, Chirgwin JM: Human renin gene: structure and sequence analysis. Proc natl Acad Sci, USA 81:5026–5030 (1984).

    External Resources

  10. Hooper NM, Karran EH, Turner AJ: Membrane protein secretases. Biochem J 321:265–279 (1997).
  11. Hussain I, Powell D, Howlett DR, Tew DG, Meek TD, Chapman C, Gloger IS, Murphy KE, Southan CD, Ryan DM, Smith ST, Simmons DL, Walsh FS, Dingwall C, Christie G: Identification of a novel aspartic protease (Asp2) as β-secretase. Mol cell Neurosci 14:419–427 (1999).

    External Resources

  12. Kang J, Lemaire HG, Unterbeck A, Salbaum JM, Masters CL, Grzeschik KH, Multhaup G, Beyreuther K, Muller-Hill B: The precursor of Alzheimer’s disease amyloid A4 protein resembles a cell-surface receptor. Nature 325:733–736 (1987).
  13. Khan AR, James MN: Molecular mechanisms for the conversion of zymogens to active proteolytic enzymes. Protein Sci 7:815–836 (1998).
  14. Koelsch G, Mares M, Metcalf P, Fusek M: Multiple functions of pro-parts of aspartic proteinase zymogens. FEBS Lett 343:6–10 (1994).
  15. Lemere CA, Blusztajn JK, Yamaguchi H, Wisniewski T, Saido TC, Selkoe DJ: Sequence of deposition of heterogeneous amyloid beta-peptides and APOE in Down syndrome: implications for initial events in amyloid plaque formation. Neurobiol Dis 3:16–32 (1996).
  16. Mann DM, Iwatsubo T, Fukumoto H, Ihara Y, Odaka A, Suzuki N: Microglial cells and amyloid beta protein (A beta) deposition; association with A beta 40-containing plaques. Acta Neuropathol 90:472–477 (1995).

    External Resources

  17. Rawlings ND, Barret AJ: Families of aspartic peptidases, and those of unknown catalytic mechanism. Meth Enzymol 248:105–136 (1995).
  18. Selkoe DJ: Translating cell biology into therapeutic advances in Alzheimer’s disease. Nature 399 (Suppl):A23–31 (1999).
  19. Seubert P, Oltersdorf T, Lee MG, Barbour R, Blomquist C, Davis DL, Bryant K, Fritz LC, Galasko D, Thal LJ, Lieberburg I, Schenk DB: Secretion of beta-amyloid precursor protein cleaved at the amino terminus of the beta-amyloid peptide. Nature 361:260–263 (1993).
  20. Sinha S, Anderson JP, Barbour R, Basi GS, Caccavello R, Davis D, Doan M, Dove HF, Frigon N, Hong J, Jacobson-Croak K, Jewett N, Keim P, Knops J, Lieberburg I, Power M, Tan H, Tatsuno G, Tung J, Schenk D, Seubert P, Suomensaari SM, Wang S, Walker D, Zhao J, McConlogue L, John V: Purification and cloning of amyloid precursor protein β-secretase from human brain. Nature 402:537–540 (1999).
  21. Sogawa K, Fujii-Kuriyama Y, Mizukami Y, Ichihara Y, Takahashi K: Primary structure of human pepsinogen gene. J biol Chem 258:5306–5311 (1983).
  22. St. George-Hyslop PH, Tanzi RE, Polinsky RJ, Haines JL, Nee L, Watkins PC, Myers RH, Feldman RG, Pollen D, Drachman D, Growdon J, Bruni A, Foncin JF, Salmon D, Frommelt P, Amaducci L, Sorbi S, Piacentini S, Stewart GD, Hobbs WJ, Conncally PM, Gusella JF: The genetic defect causing familial Alzheimer’s disease maps on chromosome 21. Science 235:885–890 (1987).
  23. Tatnell PJ, Powell DJ, Hill J, Smith TS, Tew DG, Kay J: Napsins: new human aspartic proteinases. Distinction between two closely related genes. FEBS Lett 441:43–48 (1998).
  24. Van Broeckhoven C, Genthe AM, Vandenberghe A, Horsthemke B, Backhovens H, Raeymaekers P, Van Hul W, Wehnert A, Gheuens J, Cras P, Bruyland M, Martin JJ, Salbaum M, Multhaup G, Masters CL, Begreuther K, Gurling HMD, Mullan MJ, Holland A, Barton A, Irving N, Williamson R, Richards SJ, Hardy JA: Failure of familial Alzheimer’s disease to segregate with the A4– amyloid gene in several European families. Nature 329:153–155 (1987).
  25. Vassar R, Bennet BD, Safura BK, Kahn S, Mendiaz EA, Denis P, Teplow DB, Ross S, Amarante P, Loeloff R, Luo Y, Fisher S, Fuller J, Edenson S, Lile J, Jarosinski MA, Biere AL, Curran E, Burgess T, Louis JC, Collins F, Treanor J, Rogers G, Citron M: β-Secretase cleavage of Alzheimer’s amyloid precursor protein by the transmembrane aspartic protease BACE. Science 286:735–741 (1999).
  26. Yan R, Bienkowski MJ, Shuck ME, Miao H, Tory MC, Pauley AM, Brashler JR, Sratman NC, Mathews WR, Buhl AE, Carter DB, Tomasselli AG, Parodi LA, Heinrikson RL, Gurney ME: Membrane-anchored aspartyl protease with Alzheimer’s disease β-secretase activity. Nature 402:533–537 (1999).

Pay-per-View Options
Direct payment This item at the regular price: USD 38.00
Payment from account With a Karger Pay-per-View account (down payment USD 150) you profit from a special rate for this and other single items.
This item at the discounted price: USD 26.50